← back to search

Sandra A. Mitchell

St Michaels Hospital · US
Area of research
Oncology · Hematology
Research interest
Research interests include Cancer survivorship and care, Hematopoietic Stem Cell Transplantation, Childhood Cancer Survivors' Quality of Life, and Health Systems, Economic Evaluations, Quality of Life.
h-index
60
citations
20,093
works
379
NIH funding
primary concept
Medicine
email

Recent publications

Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048)
Journal of Clinical Oncology 2023cited by 132position: middledoi
The Longitudinal Implementation Strategy Tracking System (LISTS): feasibility, usability, and pilot testing of a novel method
Implementation Science Communications 2023cited by 41position: middledoi
Development of consensus-based considerations for use of adult proxy reporting: an ISOQOL task force initiative
Journal of Patient-Reported Outcomes 2023cited by 25position: middledoi
Systematic symptom management in the IMPACT Consortium: rationale and design for 3 effectiveness-implementation trials
JNCI Cancer Spectrum 2023cited by 18position: middledoi
Systematic Review of Functional Outcomes in Cancer Rehabilitation
Archives of Physical Medicine and Rehabilitation 2022cited by 78position: middledoi
Linguistic validation of the simplified Chinese version of the US National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™)
BMC Cancer 2020cited by 168position: middledoi
Research Agenda of the Oncology Nursing Society: 2019–2022
Oncology nursing forum 2019cited by 55position: middledoi
Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols
JAMA 2018cited by 795position: middledoi
Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review
The Lancet Oncology 2018cited by 98position: middledoi
Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Journal of the American Medical Informatics Association 2018cited by 70position: middledoi
Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials
Clinical Trials 2018cited by 48position: middledoi
Symptom Trajectories Are Associated With Co-occurring Symptoms During Chemotherapy for Breast Cancer
Journal of Pain and Symptom Management 2018cited by 30position: middledoi
Trajectories of Depressed Mood and Anxiety During Chemotherapy for Breast Cancer
Cancer Nursing 2018cited by 28position: middledoi
Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial
International Journal of Radiation Oncology*Biology*Physics 2017cited by 119position: middledoi
Distinct Trajectories of Fatigue and Sleep Disturbance in Women Receiving Chemotherapy for Breast Cancer
Oncology nursing forum 2017cited by 51position: middledoi
Cancer negatively impacts on sexual function in adolescents and young adults: The AYA HOPE study
Psycho-Oncology 2016cited by 126position: middledoi
Research Priorities, Measures, and Recommendations for Assessment of Tobacco Use in Clinical Cancer Research
Clinical Cancer Research 2016cited by 95position: middledoi
Linguistic validation of the Spanish version of the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Supportive Care in Cancer 2016cited by 45position: middledoi
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Research Methodology and Study Design Working Group Report
Biology of Blood and Marrow Transplantation 2016cited by 21position: middledoi
Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
JAMA Oncology 2015cited by 1,002position: middledoi
Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report
Biology of Blood and Marrow Transplantation 2015cited by 412position: middledoi
The 2014–2018 Oncology Nursing Society Research Agenda
Oncology nursing forum 2015cited by 54position: middledoi
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
Biology of Blood and Marrow Transplantation 2014cited by 5,347position: middledoi
Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
JNCI Journal of the National Cancer Institute 2014cited by 1,108position: middledoi
Health‐related quality of life in older adult survivors of selected cancers: Data from the <scp>SEER</scp> ‐ <scp>MHOS</scp> linkage
Cancer 2014cited by 166position: middledoi
Linguistic and content validation of a German-language PRO-CTCAE-based patient-reported outcomes instrument to evaluate the late effect symptom experience after allogeneic hematopoietic stem cell transplantation
European Journal of Oncology Nursing 2014cited by 46position: middledoi
A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment
Supportive Care in Cancer 2013cited by 322position: middledoi
Symptom Distress Predicts Long-Term Health and Well-Being in Allogeneic Stem Cell Transplantation Survivors
Biology of Blood and Marrow Transplantation 2013cited by 48position: middledoi
Priorities for Oncology Nursing Research: The 2013 National Survey
Oncology nursing forum 2013cited by 45position: middledoi
Uptake and use of recommendations for the diagnosis, severity scoring and management of chronic GVHD: an international survey of the EBMT–NCI Chronic GVHD Task Force
Bone Marrow Transplantation 2013cited by 45position: middledoi

Grants

Doctoral Dissertation Research: Historical and Philosophical Analysis of the Genetic Maps in Seymour Benzer's Research on Genetic Fine Structure
NSF1230201$10,8652012–2013PIRePORTER
Conference: Modeling Complexity Across Levels: Social Insect Societies As Multilevel Integrated Systems to be held at the Santa Fe Institute, on May 22-26, 2002.
NSF0202646$10,5002002–2003PIRePORTER
Facing Up to Complexity: Integration of Theories
NSF0094395$91,0142001–2003PIRePORTER
Complexity and Critical Pluralism
NSF9710615$93,7291997–1999PIRePORTER

Frequent collaborators

Ethan Basch · UNC Lineberger Comprehensive Cancer Center8 papers (2013–2023)Amylou C. Dueck · Mayo Clinic7 papers (2013–2023)Daniel Wolff · Polyclinic Medical Center6 papers (2013–2015)Steven Z. Pavletic · National Institutes of Health6 papers (2013–2015)Lauren J. Rogak · Memorial Sloan Kettering Cancer Center6 papers (2014–2023)Deborah Watkins Bruner · Emory University6 papers (2013–2019)Deborah Schrag · Worldwide Clinical Trials (United States)5 papers (2014–2023)Tito R. Mendoza · Patient-Centered Outcomes Research Institute4 papers (2014–2017)Antonia V. Bennett · University of North Carolina at Chapel Hill4 papers (2014–2023)Bryce B. Reeve · Duke University Health System4 papers (2013–2017)Ann M. O’Mara · Massachusetts College of Pharmacy and Health Sciences4 papers (2014–2018)Hildegard Greinix · Medical College of Wisconsin3 papers (2013–2013)Geri LoBiondo‐Wood · The University of Texas at Austin3 papers (2013–2019)Charles S. Cleeland · The University of Texas MD Anderson Cancer Center3 papers (2014–2018)Bob Wong · University of Utah3 papers (2017–2018)Diane Von Ah · The Ohio State University3 papers (2013–2019)Paul J. Martin · Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa3 papers (2013–2016)Susan L. Beck · University of Arizona3 papers (2017–2018)Meagan Whisenant · The University of Texas MD Anderson Cancer Center3 papers (2017–2018)Madan Jagasia · Vanderbilt University Medical Center3 papers (2013–2015)